Common teratogenic medications
A structured approach to recognizing and managing teratogenic drug exposure in pregnancy: first-line management substitutes warfarin for enoxaparin, ACE inhibitors/ARBs for labetalol or nifedipine, and adds high-dose folic acid to prevent neural tube defects before conception in AED users.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
A teratogen disrupts normal fetal structural or functional development when exposure occurs during a susceptible window, most critically during organogenesis (weeks 3-8 post-conception).
- Epidemiology
Most teratogenic exposures happen before pregnancy is recognized, since the first missed period already falls inside the embryonic period.
- Risk factors
Exposure during the embryonic period (weeks 3-8) carries the highest risk for major structural malformation; exposure before week 3 follows an "all-or-none" pattern, and exposure after week 8 more…
- Pathophysiology
ACE inhibitors, ARBs, and direct renin inhibitors block the fetal renin-angiotensin system needed for nephrogenesis, producing renal tubular dysplasia, anuria, oligohydramnios, and secondary pulmonary hypoplasia and limb contractures.
- Clinical features
This is a pattern-recognition problem, not a syndrome the patient herself presents with: match the documented drug exposure and its gestational timing to the known malformation pattern for that agent.
- Differential diagnosis
Chromosomal aneuploidy (trisomy 21, 18, 13): malformations without a defined exposure; confirmed by cell-free fetal DNA or karyotype.
- Diagnosis
There is no single confirmatory test; the diagnosis is established by correlating a documented exposure and its gestational timing against the known malformation pattern, supported by targeted imaging and, when relevant, genetic testing.
- Management
First, confirm the exposure and its exact gestational timing, then determine whether it fell within the embryonic period (highest malformation risk) or the fetal period (growth/functional risk).
- Complications
Major structural malformation (cardiac, renal, neural tube, craniofacial, limb) requiring surgical correction, sometimes incompatible with survival (severe oligohydramnios-related pulmonary hypoplasia).
- Prognosis
Outcome depends on the specific agent, dose, and gestational window; a single dose outside the embryonic period may carry negligible structural risk.
- Prevention
Every reproductive-age woman started on a known teratogen (AEDs, isotretinoin, methotrexate, warfarin, ACE inhibitors/ARBs, lithium) should be counseled on contraception when the drug is prescribed.
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Preeclampsia
New-onset hypertension after 20 weeks of gestation with proteinuria or end-organ dysfunction, driven by abnormal placental spiral artery remodeling and widespread endothelial dysfunction. Eclampsia is preeclampsia complicated by seizures; magnesium sulfate treats and prevents seizures, and prompt delivery is the only definitive cure for both.
- Chronic hypertension in pregnancy
Chronic hypertension in pregnancy is hypertension predating pregnancy or diagnosed before 20 weeks. It raises the risk of superimposed preeclampsia, growth restriction, and abruption, so management is blood pressure control with pregnancy-safe agents, low-dose aspirin prophylaxis, close surveillance, and switching off teratogenic drugs preconception.
- Gestational hypertension
Gestational hypertension is new hypertension after 20 weeks of pregnancy without proteinuria or other features of preeclampsia. It requires close surveillance because a substantial proportion progresses to preeclampsia; management is blood pressure control with pregnancy-safe agents and timely delivery near term.
- Ectopic pregnancy
A fertilized ovum implants outside the endometrial cavity, almost always in the fallopian tube, and is the leading cause of maternal death in the first trimester. Diagnosis rests on quantitative beta-hCG paired with transvaginal ultrasound, and management branches immediately on hemodynamic stability.
- Hyperthyroidism
Hyperthyroidism is the clinical syndrome of thyroid hormone excess, produced by a range of causes from Graves disease and autonomously functioning nodules to destructive thyroiditis and exogenous hormone ingestion. Diagnosis begins with a suppressed thyroid-stimulating hormone and elevated free thyroxine, followed by radioactive iodine uptake testing or antibody measurement to identify the cause, and first-line treatment is a beta blocker for symptom control while the underlying cause directs thionamide, radioactive iodine ablation, or thyroidectomy therapy.
- Acne vulgaris
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit producing comedones, papules, pustules, and in severe disease nodules and scarring on the face, chest, and back. First-line treatment is a topical retinoid, escalating through topical or oral antibiotics paired with benzoyl peroxide, hormonal therapy, or oral isotretinoin as severity and scarring dictate.
- Bipolar I disorder
Bipolar I disorder is a chronic mood disorder defined by at least one manic episode lasting a week or requiring hospitalization, with three or more DIG FAST symptoms causing marked impairment. Diagnosis is clinical after substances and medical mimics are excluded. Acute mania is treated with lithium or valproate, often with an atypical antipsychotic, and most patients need lifelong mood-stabilizer maintenance.